Assessment of Immune Checkpoint Inhibitors and Genomic Alterations by Body Mass Index in Advanced Renal Cell Carcinoma.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 33662110.
- Also identified by DOI 10.1001/jamaoncol.2021.0019 and PMC identifier 7934079.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This cohort study examines treatment with immune checkpoint inhibitors for patients with metastatic renal cell carcinoma.
Medical subject headings
- Carcinoma, Renal Cell
- Kidney Neoplasms